Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Mar 1.

Published in final edited form as: J Viral Hepat. 2012 Aug 16;20(3):219–224. doi: 10.1111/j.1365-2893.2012.01654.x

Table 2.

Baseline characteristics

	HCC (n = 318)	CHB (n = 234)
Age, years^*	55 (30–74)^†	48 (27–86)^†
Gender, M/F, n (%)	257/61 (81/19)	195/39 (83/17)
ALT level, IU/L^*	37 (9–774)^†	150 (10–2170)^†
Total bilirubin, mg/dL^*	1.0 (0.3–14.1)	0.8 (0.3–15.4)
Albumin, g/dL^*	3.8 (1.3–4.7)^†	4.1 (2.2–5.2)^†
Prothrombin time, %^*	89 (31–119)^‡	88 (51–147)^‡
Platelet, × 10³/mm³^*	159 (22–548)^†	176 (62–556)^†
Serum AFP, ng/mL^*	51 (1–1.7 × 10⁶)^‡	5.6 (1–2150)^‡
Child-Pugh class, A/B/C, n (%)	261/50/7 (82/16/2)^†	212/14/0 (94/6/0)^†
HBeAg positivity, n (%)	82 (29)^†	189 (84)^†
Serum HBV-DNA, copies/mL^*	4.0 × 10³ (ND – 2.3 × 10⁹)	4.2 × 10⁶ (ND-1.1 × 10⁹)

HCC, hepatocellular carcinoma; CHB, chronic hepatitis B; ALT, alanine aminotransferase; AFP, α-fetoprotein; ND, not-detected.

^*

Median (range).

^†

P < 0.001.

^‡

P < 0.05.